Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE Study

INTRODUCTION: OnabotulinumtoxinA treatment for spasticity is dependent on numerous factors and varies according to selected treatment goals. OBJECTIVE: To examine real‐world onabotulinumtoxinA treatment utilization and effectiveness in patients with upper limb spasticity over 2 years from the Adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Francisco, Gerard E., Jost, Wolfgang H., Bavikatte, Ganesh, Bandari, Daniel S., Tang, Simon F.T., Munin, Michael C., Largent, Joan, Adams, Aubrey M., Zuzek, Aleksej, Esquenazi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687094/
https://www.ncbi.nlm.nih.gov/pubmed/31953896
http://dx.doi.org/10.1002/pmrj.12328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687094/
https://www.ncbi.nlm.nih.gov/pubmed/31953896
http://dx.doi.org/10.1002/pmrj.12328

Ejemplares similares